“…Furthermore, the A498V and A498T mutations exhibited, respectively, moderate and acute hypersensitivity to PAA or 9-β-D-arabinofuranosyladenine (AraA), and moderate hypersensitivity to 1-β-D-arabinofuranosylcytosine (AraC). While it is interesting that resistance to a dCTP competitor, aphidicolin, conferred increased sensitivity to, and thus likely altered affinity for, the nucleotide analogues AraA and AraC, previous studies in Herpes simplex virus and other systems have reported similar trends (Gibbs et al, 1988; Hall et al, 1989; Matsumoto et al, 1990; Nishiyama et al, 1985). Similarly, this inverse relationship between aphidicolin and PAA / nucleoside analogue resistance and sensitivity appears to hold true for the three aforementioned mutations conferring PAA resistance: C356T, G372D, G380S.…”